Supplemental material
The World Journal of Biological Psychiatry
Volume 23, 2022 - Issue 5
Original Investigations
Antipsychotic drug treatment of schizophrenia in later life: Results from the European cross-sectional AMSP study
Oliver Zolka Institute of Clinical Pharmacology of the Brandenburg Medical School, Immanuel Klinik Rüdersdorf, Rüdersdorf, GermanyCorrespondence[email protected]
https://orcid.org/0000-0002-8220-3834View further author information
https://orcid.org/0000-0002-8220-3834View further author information, Timo Greinera Institute of Clinical Pharmacology of the Brandenburg Medical School, Immanuel Klinik Rüdersdorf, Rüdersdorf, Germanyhttps://orcid.org/0000-0002-0909-570XView further author information
https://orcid.org/0000-0002-0909-570XView further author information, Michael Schneiderb University Clinic for Psychiatry and Psychotherapy of the Brandenburg Medical School, Immanuel Klinik Rüdersdorf, Rüdersdorf, Germanyhttps://orcid.org/0000-0002-3275-294XView further author information
https://orcid.org/0000-0002-3275-294XView further author information, , , , , , Tristan Zindlerd Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover, Germanyhttps://orcid.org/0000-0001-7042-0578View further author information
https://orcid.org/0000-0001-7042-0578View further author information, & Johanna Seifertd Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover, Germanyhttps://orcid.org/0000-0002-8678-7419View further author information
https://orcid.org/0000-0002-8678-7419View further author information show allRelated Research Data
Antipsychotic drug treatment of schizophrenia in later life: Results from the European cross-sectional AMSP study
Source:
Taylor & Francis
Linking provided by
